JP2002540769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540769A5 JP2002540769A5 JP2000601031A JP2000601031A JP2002540769A5 JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5 JP 2000601031 A JP2000601031 A JP 2000601031A JP 2000601031 A JP2000601031 A JP 2000601031A JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- substantially purified
- purified protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12210499P | 1999-02-26 | 1999-02-26 | |
| US60/122,104 | 1999-02-26 | ||
| PCT/US2000/004613 WO2000050453A1 (en) | 1999-02-26 | 2000-02-24 | A novel inhibitor of programmed cell death |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540769A JP2002540769A (ja) | 2002-12-03 |
| JP2002540769A5 true JP2002540769A5 (enExample) | 2007-04-26 |
Family
ID=22400634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000601031A Abandoned JP2002540769A (ja) | 1999-02-26 | 2000-02-24 | プログラム細胞死の新規抑制剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6570002B1 (enExample) |
| EP (1) | EP1161444A4 (enExample) |
| JP (1) | JP2002540769A (enExample) |
| AU (1) | AU760466B2 (enExample) |
| CA (1) | CA2363621A1 (enExample) |
| MX (1) | MXPA01008626A (enExample) |
| WO (1) | WO2000050453A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030215445A1 (en) | 1997-05-23 | 2003-11-20 | Ginette Serrero | Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| US20100111928A1 (en) * | 1997-05-23 | 2010-05-06 | A & G Pharmaceutical, Inc. | Methods and kits for diagnosis tumorgenicity |
| JP4435563B2 (ja) * | 2001-07-10 | 2010-03-17 | バイオジェン アイデック インク | アポトーシスプロセスの阻害および細胞性能の改善 |
| US7411045B2 (en) * | 2002-11-19 | 2008-08-12 | A&G Pharmaceutical, Inc. | Autocrine growth factor receptor antibodies and methods |
| AU2003901010A0 (en) * | 2003-03-06 | 2003-03-20 | Flinders Technologies Pty Ltd | Apoptosis regulator |
| US7368428B2 (en) * | 2003-06-23 | 2008-05-06 | A&G Pharmaceutical, Inc. | Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| EP1660010B1 (en) * | 2003-08-01 | 2013-07-24 | A & G Pharmaceutical, Inc. | Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| ATE451924T1 (de) | 2004-03-15 | 2010-01-15 | Sunesis Pharmaceuticals Inc | Sns-595 und anwendungsverfahren |
| US8580814B2 (en) * | 2006-04-03 | 2013-11-12 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| US8124773B2 (en) | 2006-06-12 | 2012-02-28 | Sunesis Pharmaceuticals, Inc. | 1,8-naphthyridine compounds for the treatment of cancer |
| JP2009545601A (ja) * | 2006-08-02 | 2009-12-24 | サネシス ファーマシューティカルズ， インコーポレイテッド | （＋）−１，４−ジヒドロ−７−［（３ｓ，４ｓ）−３−メトキシ−４−（メチルアミノ）−１−ピロリジニル］−４−オキソ−１−（２−チアゾリル）−１，８−ナフチリジン−３−カルボン酸の組合せ使用 |
| US8518872B2 (en) * | 2007-10-22 | 2013-08-27 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| CA2990477A1 (en) | 2015-08-12 | 2017-02-16 | Memorial Sloan-Kettering Cancer Center | Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
| US5646008A (en) | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
| US5622852A (en) | 1994-10-31 | 1997-04-22 | Washington University | Bcl-x/Bcl-2 associated cell death regulator |
| US5539094A (en) | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
| DE69434614T2 (de) | 1993-11-30 | 2006-10-05 | Tanox, Inc., Houston | Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung |
| US5858678A (en) | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
| US5858715A (en) | 1997-01-29 | 1999-01-12 | Incyte Pharmaceuticals, Inc. | Human apoptosis-associated protein |
-
2000
- 2000-02-24 US US09/512,346 patent/US6570002B1/en not_active Expired - Lifetime
- 2000-02-24 EP EP00911926A patent/EP1161444A4/en not_active Withdrawn
- 2000-02-24 CA CA002363621A patent/CA2363621A1/en not_active Abandoned
- 2000-02-24 WO PCT/US2000/004613 patent/WO2000050453A1/en not_active Ceased
- 2000-02-24 MX MXPA01008626A patent/MXPA01008626A/es unknown
- 2000-02-24 AU AU33740/00A patent/AU760466B2/en not_active Ceased
- 2000-02-24 JP JP2000601031A patent/JP2002540769A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003515323A5 (enExample) | ||
| JP2002519061A5 (enExample) | ||
| JP2006516098A5 (enExample) | ||
| JP2004501162A5 (enExample) | ||
| JP2002524024A5 (enExample) | ||
| JP2003525623A5 (enExample) | ||
| JPH1072351A5 (enExample) | ||
| WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
| AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
| WO2004035618A3 (en) | Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof | |
| JP2004532624A5 (enExample) | ||
| JP2004508843A5 (enExample) | ||
| WO2002016617A3 (en) | Myrosinase from brevicoryne brassicae | |
| IL156799A0 (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
| AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
| JP2005179268A5 (enExample) | ||
| WO2001053347A3 (fr) | Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
| JP2001078180A5 (enExample) | ||
| JP2006510360A5 (enExample) | ||
| ATE353913T1 (de) | Neue collectine | |
| AU2003264535A1 (en) | Tumor antigen protein and utilization thereof | |
| WO2003020759A3 (en) | A caspase- 8 binding protein, its preparation and use | |
| GB0030309D0 (en) | Antibodies,Peptides,Analogs and uses thereof | |
| WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
| JPH1132773A5 (enExample) |